The vascular phenotype of melanoma metastasis

Clinical and Experimental Metastasis

Volumn 20, Issue 3, 2003, Pages 229-235

  Velazquez, Omaida C ^a,b   Herlyn, Meenhard ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Melanoma; Stromal precursors; Vascular phenotype

Indexed keywords

ANGIOGENESIS; BONE MARROW; CANCER CELL; CANCER INVASION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL INTERACTION; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MELANOMA CELL; METASTASIS; PHENOTYPE; REVIEW; SIGNAL TRANSDUCTION;

CELL COMMUNICATION; ENDOTHELIUM, VASCULAR; FIBROBLASTS; HEMATOPOIETIC STEM CELLS; HUMANS; MELANOMA; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 0037279469     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022987201264     Document Type: Review

References (52)

1. Al-Mehdi AB, Tozawa K, Fisher AB et al. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 2002; 6: 100-2.
2. Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 2002; 156: 361-81.
3. Maniotis AJ, Folberg R, Hess A et al. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry. Am J Pathol 1999; 155: 739-52.
4. Peichev M, Naiyer AJ, Pereira D et al. Expression of VEGFR-2 and AC 133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-8.
5. Ikpeazu C, Davidson MK, Halteman D et al. Donor origin of circulating endothelial progenitors after allogeneic bone marrow transplantation. Biol Blood Marrow Transplant 2000; 6: 301-8.
6. Takahashi T, Kalka C, Masuda H et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-8.
7. Reyes M, Dudek A, Jahagirdar B et al. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002; 109: 337-46.
8. Velazquez OC, Snyder R, Liu ZJ et al. Fibroblast-dependent differentiation of human microvascular endothelial cells into capillary-like, three-dimensional networks. Faseb J 2002; in press.
9. Chin L, Tam A, Pomerantz J et al. Essential role for oncogenic Ras in tumour maintenance. Nature 1999; 400: 468-72.
10. Herlyn M, Malkowicz SB. Regulatory pathways in tumor growth and invasion. Lab Invest 1991; 65: 262-71.
11. Chambers AF. The metastatic process: basic research and clinical implications. Oncol Res 1999; 11: 161-8.
12. Naumov GN, MacDonald IC, Chambers AF et al. Solitary cancer cells as a possible source of tumour dormancy? Semin Cancer Biol 2001; 11: 271-6.
13. Hendrix MJ, Seftor EA, Meltzer PS et al. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry. Proc Natl Acad Sci USA 2001; 98: 8018-23.
14. Hess AR, Seftor E, Gardner LM et al. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: Role of epithelial cell kinase (Eck/EphA2). Cancer Res 2001; 61: 3250-5.
15. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-57.
16. Smith RS, Smith TJ, Blieden TM et al. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol 1997; 151: 317-22.
17. Laterra J, Guerin C, Goldstein GW. Astrocytes induce neural microvascular endothelial cells to form capillary-like structures in vitro. J Cell Physiol 1990; 144: 204-15.
18. Montesano R, Pepper MS, Orci L. Paracrine induction of angiogenesis in vitro by Swiss 3T3 fibroblasts. J Cell Sci 1993; 105: 1013-24.
19. Hellstrom M, Gerhardt H, Kalen M et al. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 2001; 153: 543-53.
20. Carmeliet P, Conway EM. Growing better blood vessels. Nat Biotechnol 2002; 19: 1019-20.
21. Benjamin LE. The controls of microvascular survival. Cancer Metastasis Rev 2000; 19: 75-81.
22. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-7.
23. Asahara T, Takahashi T, Masuda H et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999; 18: 3964-72.
24. Kalka C, Tehrani H, Laudenberg B et al. VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease. Ann Thorac Surg 2000; 70: 829-34.
25. Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 1999; 103: 1231-6.
26. Kamihata H, Matsubara H, Nishiue T et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001; 104: 1046-52.
27. Reyes M, Lund T, Lenvik T et al. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2002; 98: 2615-25.
28. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-9.
29. Harraz M, Jiao C, Hanlon HD et al. CD34- blood-derived human endothelial cell progenitors. Stem Cells 2001; 19: 304-12.
30. Masuda H, Kalka C, Asahara T. Endothelial progenitor cells for regeneration. Hum Cell 2000; 13: 153-60.
31. Kawamoto A, Gwon HC, Iwaguro H et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 2001; 103: 634-7.
32. Shintani S, Murohara T, Ikeda H et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001; 103: 2776-9.
33. Freedman SB, Isner JM. Therapeutic angiogenesis for ischemic cardiovascular disease. J Mol Cell Cardiol 2001; 33: 379-93.
34. Asahara T, Kalka C, Isner JM. Stem cell therapy and gene transfer for regeneration. Gene Ther 2000; 7: 451-7.
35. Kaushal S, Amiel GE, Guleserian KJ et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001; 7: 1035-40.
36. Crosby JR, Kaminski WE, Schatteman G et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 2000; 87: 728-30.
37. Murohara T, Ikeda H, Duan J et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105: 1527-36.
38. Schatteman GC, Hanlon HD, Jiao C et al. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 2000; 106: 571-8.
39. Gehling UM, Ergun S, Schumacher U et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95: 3106-12.
40. Lin Y, Weisdorf DJ, Solovey A et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105: 71-7.
41. Hsu MY, Meier FE, Nesbit M et al. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol 2000; 156: 1515-25.
42. Hsu MY, Shih DT, Meier FE et al. Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma. Am J Pathol 1998; 153: 1435-42.
43. Satyamoorthy K, Muyrers J, Meier F et al. Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication. Oncogene 2001; 20: 4676-84.
44. St Croix B, Rago C, Velculescu V et al. Genes expressed in human tumor endothelium. Science 2000; 289: 1197-1202.
45. Gutheil JC, Campbell TN, Pierce PR et al. Targeted antiangiogenic therapy for cancer using Vitaxin: A humanized monoclonal antibody to the integrin alphavbeta3. Clin Cancer Res 2000; 6: 3056-61.
46. Eliceiri BP, Cheresh DA. Role of alpha v integrins during angiogenesis. Cancer J Sci Am 6 Suppl 2000; 3: S245-9.
47. Eliceiri BP, Cheresh DA. The role of alphav integrins during angiogenesis: Insights into potential mechanisms of action and clinical development. J Clin Invest 1999; 103: 1227-30.
48. Eliceiri P, Cheresh DA. The role of alphav integrins during angiogenesis. Mol Med 1998; 4: 741-50.
49. Cheresh DA, Stupack DG. Integrin-mediated death: An explanation of the integrin- knockout phenotype? Nat Med 2002; 8: 193-4.
50. Reynolds LE, Wyder L, Lively JC et al. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med 2002; 8: 27-34.
51. Berking C, Herlyn M. Human skin reconstruct models: A new application for studies of melanocyte and melanoma biology. Histol Histopathol 2001; 16: 669-74.
52. Satyamoorthy K, Meier F, Hsu MY et al. Human xenografts, human skin and skin reconstructs for studies in melanoma development and progression. Cancer Metastasis Rev 1999; 18: 401-5.